Review article: the therapy of gastrointestinal infections associated with the acquired immunodeficiency syndrome.
Although there have been dramatic strides in the therapy of human immunodeficiency virus infection over the last few years, the number of infected people world-wide is tremendous and, at least in developing countries, continues to expand. Complications which involve the gastrointestinal tract are common in these patients, because the gut is a major site for involvement by opportunistic infections and neoplasms in patients with the acquired immunodeficiency syndrome. It is important to recognize the clinical spectrum of gastrointestinal diseases, as well as the appropriate and most cost-effective diagnostic strategies, as therapies for a number of these disorders are both widely available and high effective. This review summarizes the major gastrointestinal infections which are seen in patients with the acquired immunodeficiency syndrome, and their treatment.
Wilcox
C M
CM
Department of Medicine, University of Alabama of Birmingham 35294-0007.
Mönkemüller
K E
KE
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000935:Antifungal Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy; D002180:Candidiasis, Oral / Q000150:complications / Q000628:therapy; D004351:Drug Resistance; D004942:Esophagitis, Peptic / Q000188:drug therapy; D005767:Gastrointestinal Diseases / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D016867:Immunocompromised Host; D007239:Infections / Q000150:complications / Q000188:drug therapy*; D009164:Mycobacterium Infections / Q000188:drug therapy; D011528:Protozoan Infections / Q000188:drug therapy; D014777:Virus Diseases / Q000188:drug therapy
D000935:Antifungal Agents